Equity InsiderAI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030Equity Insider•15 min read
Equity InsiderBefore Anything Flies to Space, It Has to Be Built, Tested, and Proven on the Ground, and That Quiet Bottleneck Is Becoming a BusinessEquity Insider•13 min read
Equity InsiderSilver Is in Its Sixth Straight Year of Deficit, and the Hunt for Grade Is Pulling Capital Back to the Districts That Built the Industry.Equity Insider•14 min read
Equity InsiderGovernments Just Put a Deadline on Encryption, and a Quiet Corner of Cybersecurity Is Suddenly on the Clock.Equity Insider•12 min read
Equity InsiderA Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to CaptureEquity Insider•14 min read
Equity InsiderThe Real Cost of a New Home Isn't Just the House. It's Everyone Who Has to Touch It Along the Way.Equity Insider•13 min read
Equity InsiderA Metal With Few Substitutes, a Supply Chain Dominated by One Country, and a Historic Canadian Tungsten Zone Being Drill-Tested AgainEquity Insider•14 min read
Equity InsiderSilver's Best Year Since 2010 Is Sending Explorers Back to Deposits the Majors Left BehindEquity Insider•14 min read
Equity InsiderA Utility Ran the Numbers on a Battery It Could Pick Up and Move, Then Bought Two of Them OutrightEquity Insider•13 min read
Equity InsiderA Carried 25% Stake in an Ecuador Copper-Gold Mine Just Got 121% More Valuable, and the Country Just Made Exploration CheaperEquity Insider•15 min read
Equity InsiderThe West Is Losing Refineries Faster Than It Can Replace Them, and One Nasdaq Company Has the Only One in NevadaEquity Insider•17 min read
Equity InsiderA Greenland Deposit Just Got Its First U.S.-Compliant Resource Report, and the Indicated Grade Jumped 36%Equity Insider•16 min read
Equity InsiderOttawa Just Picked This Small Canadian Company to Represent Its Quantum Technology in EuropeEquity Insider•13 min read
Equity InsiderAmerica Wants a Uranium Supply Chain and an AI-Ready Reactor Fleet, and One Nasdaq Company Is Trying to Build Both at OnceEquity Insider•16 min read
Equity InsiderThe GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.Equity Insider•12 min read
Equity InsiderThe AI Boom Ran Into a Power Wall; This Nasdaq Company Is Building the Battery That Rolls In to Fix ItEquity Insider•9 min read
